Immuron Limited
IMRN
$2.35
$0.146.34%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 25.65% | 23.30% | 69.54% | 73.52% | 105.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.65% | 23.30% | 69.54% | 73.52% | 105.81% |
| Cost of Revenue | 45.59% | 42.92% | 72.49% | 76.52% | 957.24% |
| Gross Profit | 16.68% | 14.49% | 68.10% | 72.05% | 32.03% |
| SG&A Expenses | 1.52% | -0.39% | 43.89% | 47.27% | 36.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 55.55% | 56.38% | 62.75% | 61.88% | -57.90% |
| Total Operating Expenses | 3.43% | 1.49% | 49.29% | 52.78% | 105.15% |
| Operating Income | 14.28% | 15.88% | -25.68% | -28.59% | -104.66% |
| Income Before Tax | 45.49% | 46.51% | -20.03% | -22.83% | -165.38% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 45.49% | 46.51% | -20.03% | -22.83% | -165.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.49% | 46.51% | -20.03% | -22.83% | -165.38% |
| EBIT | 14.28% | 15.88% | -25.68% | -28.59% | -104.66% |
| EBITDA | 14.43% | 15.93% | -25.75% | -28.69% | -106.44% |
| EPS Basic | 47.14% | 47.14% | -16.67% | -20.00% | -159.26% |
| Normalized Basic EPS | 41.03% | 41.03% | -15.79% | -21.05% | -225.00% |
| EPS Diluted | 47.14% | 47.14% | -20.00% | -23.33% | -159.26% |
| Normalized Diluted EPS | 41.03% | 41.03% | -15.79% | -21.05% | -225.00% |
| Average Basic Shares Outstanding | 2.38% | 2.38% | 0.32% | 0.32% | 0.05% |
| Average Diluted Shares Outstanding | 2.38% | 2.38% | 0.32% | 0.32% | 0.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |